Athenahealth Goes in Search of a Suitor

The transcript discusses a report from the New York Post about a bidding process for Athena, which is largely inaccurate. There are at least five bidders, both strategic and financial, with bids expected above $135 per share. Speculation surrounds Pamplona Capital and NThrive's involvement, though Athena has not engaged with them. Elliot, a significant shareholder, is expected to be part of the buyer group. The valuation is expected to be between $140 and $150 per share, with hopes of concluding the deal by the end of the month.

Who are the potential bidders mentioned in the report?

What is the current status of the bidding process for Athenahealth?

What role has Elliot played in the situation with Athenahealth?

What are the implications of a potential merger between Nthrive and Athenahealth?

What are the expected price ranges for Athenahealth's shares?